Search results
Found 9927 matches for
We would like to congratulate Dr Luke Jostins-Dean on being awarded a 5-year Sir Henry Dale fellowship, joint funded by the Wellcome Trust and Royal Society, entitled ‘combining genetics and high-resolution cell phenotyping to map pathways underlying inflammatory bowel disease’.
Dendrou Group | Immune Disease Multiomics
Our research aims to compare inflammatory diseases and immunological responses across tissues, over time and upon perturbation for translational benefit, leveraging multiomic technologies.
Progatzky Group | Peripheral glia and immunity
Our research aims to elucidate the role of peripheral glial cells in tissue health and disease.
Vincent Group | Molecular Pathogenesis of Osteoarthritis
Our research focuses on all aspects of osteoarthritis, from understanding its causes to developing new treatments for the condition to improve people's quality of life.
Williams Group | Targeting Disease Pathways in Rheumatoid Arthritis
Our work is geared towards the development of new treatments and healthcare strategies for rheumatoid arthritis and other autoimmune diseases.
Luo Group | Statistical genomics and computational immunology
We develop statistical methods and computational software to better understand the genetic contribution to immune-mediated traits.
Johnson Group | Microbiome and Multi-omics
Applying multi-omic and computational genomic approaches to understand the molecular basis of host-microbiome interactions
Centre for OA Pathogenesis
Established in 2013, the Arthritis Research UK Centre of Excellence aims to develop new treatments for this disabling condition, improving healthcare and transforming people's lives.
FUNDING BODY
SPONSOR
-
Fiona Powrie FRS
Professor of Musculoskeletal Sciences and Director of the Kennedy Institute
Our research themes
Similar stories
£1.4m awarded to investigate how tumour mechanics affect the immune response to cancer
24 June 2025
Professor Marco Fritzsche from the Kennedy Institute of Rheumatology, is co-leading a research project that has been awarded a £1.4 million Programme Foundation Award from Cancer Research UK, to investigate how physical forces within tumours affect the ability of a type of white blood cell to attack and eliminate cancer cells.